Procaps Group S.A.
NASDAQ: PROC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jose Antonio Toledo Vieira
- Employees
- 5,500
- Headquarters
- Luxembourg City, Luxembourg
- IPO year
- 2019
- Market cap
- $102.1M
- Website
- https://www.procapsgroup.com
Loading PROC…
Loading profile data…Frequently asked questions about PROC
What does Procaps Group S.A. (PROC) do?
Procaps Group S.A., established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical solutions. The company manufactures and markets branded prescription medications addressing diverse therapeutic needs, including women's health, pain...
Where does PROC trade?
Procaps Group S.A. (PROC) trades on the NASDAQ Global Market.
What sector is PROC in?
Procaps Group S.A. (PROC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Procaps Group S.A.?
Jose Antonio Toledo Vieira is the chief executive officer of Procaps Group S.A. (PROC).
Where is Procaps Group S.A. headquartered?
Procaps Group S.A. is headquartered in Luxembourg.
Does PROC pay a dividend?
Procaps Group S.A. (PROC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PROC go public?
Procaps Group S.A. (PROC) completed its initial public offering in 2019.